世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000034216

個別化医療向けバイオマーカーの世界市場規模調査・予測:適応症別、用途別、地域別の分析(2022年〜2029年)

Bizwit Research & Consulting LLP

Global Personalized Medicine Biomarkers Market Size study & Forecast, by Indication (Oncology, Diabetes, Autoimmune Diseases, Cardiology, Others) by Application (Early Detection/Screening, Diagnosis, Treatment Selection, Monitoring) and Regional Analysis, 2022-2029

発刊日 2023/01/25

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000034216

Single
Enterprise (Global Site)

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

世界の個別化医療向けバイオマーカー市場は、2021年に約117億6,000万米ドルと評価され、予測期間の2022年から2029年には15.51%以上の健全な成長率で成長すると予想されています。個別化医療向けバイオマーカーは、特定の薬剤による治療に適した患者を選択し、個別化医療を可能にするために特別に設計された必須ツールです。これは、適切な患者に、適切な量を、適切なタイミングで、適切な治療を提供することに重点を置いています。慢性疾患の増加、予後の分析および投与量の選択に対する認識と意義の高まり、早期診断と治療の提供に対する要求の高まりが、世界的な市場の需要に拍車をかけています。

個別化医療の需要の急増は、世界市場における個別化医療向けバイオマーカーの需要に直結しています。Statistaによると、2019年の個別化医療の世界市場は約1兆9,800億米ドルであり、2022年には2兆7,700億米ドルに達すると推測されています。したがって、個別化医療に対する需要の高まりは、すべての患者に効果的で安全な治療法を作成することであり、その結果、世界的に市場の成長が促進されます。慢性疾患の検出は、予測年にわたってさまざまな有利な機会を提示しています。ただし、規制と償還のハードル、多額の設備投資、およびバイオマーカー開発への長いタイムラインが、2022年から2029年の予測期間を通じて市場の成長を妨げています。

個別化医療向けバイオマーカーの世界市場の調査対象地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域です。北アメリカは、バイオマーカーへの資金提供の増加、技術的進歩の増加、主要な市場プレイヤーの存在などにより、収益面で市場を支配しています。一方、アジア太平洋地域は、予測期間中に最も高いCAGRで成長すると予想されています。これは、この地域の市場において、政府の資金提供やイニシアチブの利用可能性、医療改革の進展、がんのスクリーニング検査の利用率の上昇といった要因によるものです。

調査範囲

  • 調査企業
    ➣ Laboratory Corporation of America Holding
    ➣ Quest Diagnostics Incorporated
    ➣ Agilent Technologies, Inc.
    ➣ Genome Medical, Inc.
    ➣ Coriell Life Sciences.
    ➣ Thermo Fisher Scientific Inc.
    ➣ NeoGenomics Laboratories
    ➣ Foundation Medicine, Inc.
    ➣ Illumina, Inc.
    ➣ Guardant Health
  • 調査対象年
    ➣ 実績データ - 2019年、2020年、2021年
    ➣ 基準年 - 2021年
    ➣ 予測期間 - 2022年から2029年

本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。

さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

  • 市場セグメント・サブセグメント
    ➣ 適応症別
      ◇ 腫瘍学
      ◇ 糖尿病
      ◇ 自己免疫疾患
      ◇ 心臓病学
      ◇ その他
    ➣ 用途別
      ◇ 早期発見・スクリーニング
      ◇ 診断
      ◇ 治療の選択
      ◇ モニタリング
    ➣ 地域別
      ◇ 北アメリカ
       ✓ アメリカ
       ✓ カナダ
      ◇ ヨーロッパ
       ✓ イギリス
       ✓ ドイツ
       ✓ フランス
       ✓ スペイン
       ✓ イタリア
       ✓ その他のヨーロッパ
      ◇ アジア太平洋地域
       ✓ 中国
       ✓ インド
       ✓ 日本
       ✓ オーストラリア
       ✓ 韓国
       ✓ その他のAPAC
      ◇ ラテンアメリカ
       ✓ ブラジル
       ✓ メキシコ
       ✓ 世界のその他の地域

レポート詳細

目次

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Personalized Medicine Biomarkers Market, by Region, 2019-2029 (USD Billion)
1.2.2. Personalized Medicine Biomarkers Market, by Indication, 2019-2029 (USD Billion)
1.2.3. Personalized Medicine Biomarkers Market, by Application, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Personalized Medicine Biomarkers Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Personalized Medicine Biomarkers Market Dynamics
3.1. Personalized Medicine Biomarkers Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising awareness and significance of analyzing the prognosis and selection of dose
3.1.1.2. Surging demand for personalized medicine
3.1.2. Market Challenges
3.1.2.1. Regulatory & reimbursement hurdles
3.1.2.2. High capital investments and lengthy timelines for biomarker development
3.1.3. Market Opportunities
3.1.3.1. Growing investment in research & development activities
3.1.3.2. Technological advancements in the diagnosis and detection of chronic diseases

Chapter 4. Global Personalized Medicine Biomarkers Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Personalized Medicine Biomarkers Market, by Indication
6.1. Market Snapshot
6.2. Global Personalized Medicine Biomarkers Market by Indication, Performance - Potential Analysis
6.3. Global Personalized Medicine Biomarkers Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
6.4. Personalized Medicine Biomarkers Market, Sub Segment Analysis
6.4.1. Oncology
6.4.2. Diabetes
6.4.3. Autoimmune Diseases
6.4.4. Cardiology
6.4.5. Others

Chapter 7. Global Personalized Medicine Biomarkers Market, by Application
7.1. Market Snapshot
7.2. Global Personalized Medicine Biomarkers Market by Application, Performance - Potential Analysis
7.3. Global Personalized Medicine Biomarkers Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Personalized Medicine Biomarkers Market, Sub Segment Analysis
7.4.1. Early Detection/Screening
7.4.2. Diagnosis
7.4.3. Treatment Selection
7.4.4. Monitoring

Chapter 8. Global Personalized Medicine Biomarkers Market, Regional Analysis
8.1. Personalized Medicine Biomarkers Market, Regional Market Snapshot
8.2. North America Personalized Medicine Biomarkers Market
8.2.1. U.S. Personalized Medicine Biomarkers Market
8.2.1.1. Indication breakdown estimates & forecasts, 2019-2029
8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Personalized Medicine Biomarkers Market
8.3. Europe Personalized Medicine Biomarkers Market Snapshot
8.3.1. U.K. Personalized Medicine Biomarkers Market
8.3.2. Germany Personalized Medicine Biomarkers Market
8.3.3. France Personalized Medicine Biomarkers Market
8.3.4. Spain Personalized Medicine Biomarkers Market
8.3.5. Italy Personalized Medicine Biomarkers Market
8.3.6. Rest of Europe Personalized Medicine Biomarkers Market
8.4. Asia-Pacific Personalized Medicine Biomarkers Market Snapshot
8.4.1. China Personalized Medicine Biomarkers Market
8.4.2. India Personalized Medicine Biomarkers Market
8.4.3. Japan Personalized Medicine Biomarkers Market
8.4.4. Australia Personalized Medicine Biomarkers Market
8.4.5. South Korea Personalized Medicine Biomarkers Market
8.4.6. Rest of Asia Pacific Personalized Medicine Biomarkers Market
8.5. Latin America Personalized Medicine Biomarkers Market Snapshot
8.5.1. Brazil Personalized Medicine Biomarkers Market
8.5.2. Mexico Personalized Medicine Biomarkers Market
8.5.3. Rest of Latin America Personalized Medicine Biomarkers Market
8.6. Rest of The World Personalized Medicine Biomarkers Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Laboratory Corporation of America Holding
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Quest Diagnostics Incorporated
9.2.3. Agilent Technologies, Inc.
9.2.4. Genome Medical, Inc.
9.2.5. Coriell Life Sciences.
9.2.6. Thermo Fisher Scientific Inc.
9.2.7. NeoGenomics Laboratories
9.2.8. Foundation Medicine, Inc.
9.2.9. Illumina, Inc.
9.2.10. Guardant Health

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

List of Tables
TABLE 1. Global Personalized Medicine Biomarkers Market, report scope
TABLE 2. Global Personalized Medicine Biomarkers Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Personalized Medicine Biomarkers Market estimates & forecasts by Indication 2019-2029 (USD Billion)
TABLE 4. Global Personalized Medicine Biomarkers Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 5. Global Personalized Medicine Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Personalized Medicine Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Personalized Medicine Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Personalized Medicine Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Personalized Medicine Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Personalized Medicine Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Personalized Medicine Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Personalized Medicine Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Personalized Medicine Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Personalized Medicine Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Personalized Medicine Biomarkers Market
TABLE 70. List of primary sources, used in the study of global Personalized Medicine Biomarkers Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable

List of figures
FIG 1. Global Personalized Medicine Biomarkers Market, research methodology
FIG 2. Global Personalized Medicine Biomarkers Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Personalized Medicine Biomarkers Market, key trends 2021
FIG 5. Global Personalized Medicine Biomarkers Market, growth prospects 2022-2029
FIG 6. Global Personalized Medicine Biomarkers Market, porters 5 force model
FIG 7. Global Personalized Medicine Biomarkers Market, pest analysis
FIG 8. Global Personalized Medicine Biomarkers Market, value chain analysis
FIG 9. Global Personalized Medicine Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Personalized Medicine Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Personalized Medicine Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Personalized Medicine Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Personalized Medicine Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Personalized Medicine Biomarkers Market, regional snapshot 2019 & 2029
FIG 15. North America Personalized Medicine Biomarkers Market 2019 & 2029 (USD Billion)
FIG 16. Europe Personalized Medicine Biomarkers Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Personalized Medicine Biomarkers Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Personalized Medicine Biomarkers Market 2019 & 2029 (USD Billion)
FIG 19. Global Personalized Medicine Biomarkers Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable

この商品のレポートナンバー

0000034216

TOP